--2024/H1861.300K / ----
Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Apple
AAPL
AU Stock MarketDetailed Quotes
NUZ Neurizon Therapeutics Ltd
- 0.120
- 0.0000.00%
20min DelayTrading May 1 10:07 AET
59.08MMarket Cap-5.71P/E (Static)
0.120High0.120Low127.00KVolume0.120Open0.120Pre Close15.24KTurnover0.24552wk High0.04%Turnover Ratio492.31MShares0.09652wk Low-0.021EPS TTM42.16MFloat Cap0.245Historical HighLossP/E (Static)351.37MShs Float0.096Historical Low-0.021EPS LYR0.00%Amplitude--Dividend TTM5.00P/B1Lot Size--Div YieldTTM
Neurizon Therapeutics Ltd Key Stats
Neurizon Therapeutics Ltd Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: AUD
Actual
Estimate
Neurizon Therapeutics Ltd Earnings Reports
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts